Rheumatology outcomes: the patient's perspective - PubMed (original) (raw)
Affiliations
- PMID: 12672221
Rheumatology outcomes: the patient's perspective
Alison Carr et al. J Rheumatol. 2003 Apr.
Abstract
Our aim was to explore the patient's perspective of outcomes in rheumatoid arthritis (RA) to identify which outcomes are important to patients and how patients calibrate what constitutes a meaningful change in those outcomes. A qualitative study was performed using focus groups in 5 clinical centers in different geographical locations in the UK. Each group contained 6 to 9 patients with RA who were purposefully sampled to include men and women with a range of age, disease duration, functional disability, work disability, and current disease activity. Each focus group lasted around 1 h and addressed 3 questions: What outcomes from treatment are important to RA patients? What makes patients satisfied or dissatisfied with a treatment? How do patients decide that a treatment is working? Patients identified as important not only physical outcomes such as pain and disability, but also fatigue and a general feeling of wellness. The relative importance of these outcomes depended on the stage of disease and on specific situations, such as a disease flare. Satisfaction was influenced by communication, access to treatment, and treatment efficacy. Treatment efficacy was related to symptom reduction, with the magnitude of reduction necessary for efficacy dependent on the stage of disease. For example, large changes were deemed necessary with disease of long duration, while in early disease, even small changes could be important. Our data support existing knowledge of the importance of pain and mobility as treatment outcomes, but raise new and important issues: Some outcomes of importance to patients are not currently measured and there are no measures available to capture them. Existing measures need to be calibrated to take account of the differing importance of outcomes at different stages of disease and variations in the magnitude of change within the same outcome that indicate treatment efficacy.
Similar articles
- Rheumatology outcomes: the patient's perspective. A multicentre focus group interview study of Swedish rheumatoid arthritis patients.
Ahlmén M, Nordenskiöld U, Archenholtz B, Thyberg I, Rönnqvist R, Lindén L, Andersson AK, Mannerkorpi K. Ahlmén M, et al. Rheumatology (Oxford). 2005 Jan;44(1):105-10. doi: 10.1093/rheumatology/keh412. Epub 2004 Sep 20. Rheumatology (Oxford). 2005. PMID: 15381792 - Outcomes from the Patient Perspective Workshop at OMERACT 6.
Kirwan J, Heiberg T, Hewlett S, Hughes R, Kvien T, Ahlmèn M, Boers M, Minnock P, Saag K, Shea B, Suarez Almazor M, Taal E. Kirwan J, et al. J Rheumatol. 2003 Apr;30(4):868-72. J Rheumatol. 2003. PMID: 12672218 Review. - Progress since OMERACT 6 on including patient perspective in rheumatoid arthritis outcome assessment.
Kirwan JR, Ahlmén M, de Wit M, Heiberg T, Hehir M, Hewlett S, Katz PP, Minnock P, Quest EM, Richards P. Kirwan JR, et al. J Rheumatol. 2005 Nov;32(11):2246-9. J Rheumatol. 2005. PMID: 16265711 - Incorporating the patient perspective into outcome assessment in rheumatoid arthritis--progress at OMERACT 7.
Kirwan JR, Hewlett SE, Heiberg T, Hughes RA, Carr M, Hehir M, Kvien TK, Minnock P, Newman SP, Quest EM, Taal E, Wale J. Kirwan JR, et al. J Rheumatol. 2005 Nov;32(11):2250-6. J Rheumatol. 2005. PMID: 16265712 - Rheumatoid arthritis patient education: RA patients' experience.
Mäkeläinen P, Vehviläinen-Julkunen K, Pietilä AM. Mäkeläinen P, et al. J Clin Nurs. 2009 Jul;18(14):2058-65. doi: 10.1111/j.1365-2702.2008.02763.x. J Clin Nurs. 2009. PMID: 19638061
Cited by
- What do patients prefer? A multinational, longitudinal, qualitative study on patient-preferred treatment outcomes in early rheumatoid arthritis.
Van der Elst K, Mathijssen EGE, Landgren E, Bremander A, De Groef A, Lindqvist E, Nylander M, Peters A, Van den Hoogen F, van Eijk-Hustings Y, Verhoeven G, Vriezekolk JE, Westhovens R, Larsson I. Van der Elst K, et al. RMD Open. 2020 Sep;6(2):e001339. doi: 10.1136/rmdopen-2020-001339. RMD Open. 2020. PMID: 32938747 Free PMC article. - Self-management of fatigue in rheumatoid arthritis: a randomised controlled trial of group cognitive-behavioural therapy.
Hewlett S, Ambler N, Almeida C, Cliss A, Hammond A, Kitchen K, Knops B, Pope D, Spears M, Swinkels A, Pollock J. Hewlett S, et al. Ann Rheum Dis. 2011 Jun;70(6):1060-7. doi: 10.1136/ard.2010.144691. Ann Rheum Dis. 2011. PMID: 21540202 Free PMC article. Clinical Trial. - Developing Smartphone-Based Objective Assessments of Physical Function in Rheumatoid Arthritis Patients: The PARADE Study.
Hamy V, Garcia-Gancedo L, Pollard A, Myatt A, Liu J, Howland A, Beineke P, Quattrocchi E, Williams R, Crouthamel M. Hamy V, et al. Digit Biomark. 2020 Apr 30;4(1):26-43. doi: 10.1159/000506860. eCollection 2020 Jan-Apr. Digit Biomark. 2020. PMID: 32510034 Free PMC article. - Patient experiences, attitudes and expectations towards receiving information about anti-TNF medication: a quantitative study.
Packham J, Arkell P, Sheeran T, Brownfield A, Cadwgan A, Ryan S. Packham J, et al. Clin Rheumatol. 2017 Nov;36(11):2595-2600. doi: 10.1007/s10067-017-3642-5. Epub 2017 May 19. Clin Rheumatol. 2017. PMID: 28526972 Free PMC article. - Effects of tofacitinib monotherapy on patient-reported outcomes in a randomized phase 3 study of patients with active rheumatoid arthritis and inadequate responses to DMARDs.
Strand V, Kremer J, Wallenstein G, Kanik KS, Connell C, Gruben D, Zwillich SH, Fleischmann R. Strand V, et al. Arthritis Res Ther. 2015 Nov 4;17:307. doi: 10.1186/s13075-015-0825-9. Arthritis Res Ther. 2015. PMID: 26530039 Free PMC article. Clinical Trial.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical